REFERENCES
  1. Steyerberg EW, Vergouwe Y. Towards better clinical prediction models: seven steps for development and an ABCD for validation. European heart journal. 2014 Jun 4; 35(29):1925-31.
  2. Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. Springer Science & Business Media; 2008 Dec 16.
  3. Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Annals of internal medicine. 1999 Mar 16; 130(6):515-24.
  4. Kuhn M, Johnson K. Applied predictive modeling. New York: Springer; 2013 May 17.
  5. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW. Assessing the performance of prediction models: a framework for some traditional and novel measures. Epidemiology (Cambridge, Mass.). 2010 Jan; 21(1):128.
  6. Lee YH, Bang H, Kim DJ. How to establish clinical prediction models. Endocrinology and Metabolism. 2016 Mar 1; 31(1):38-44.
  7. Parikh NI, Pencina MJ, Wang TJ, Benjamin EJ, Lanier KJ, Levy D, D’Agostino RB, Kannel WB, Vasan RS. A risk score for predicting the near-term incidence of hypertension: the Framingham Heart Study. Annals of internal medicine. 2008 Jan 15; 148(2):102-10.
  8. Kivimaki M, Batty GD, Singh-Manoux A, Ferrie JE, Tabak AG, Jokela M, Marmot MG, Smith GD, Shipley MJ. Validating the Framingham hypertension risk score: results from the Whitehall II Study. Hypertension. 2009 Sep 1; 54(3):496-501.